Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 116   

Articles published

4502 4,547.00 -16.00 (-0.35%)
price chart
Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership ...
Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. (TSE:4502) from the realm of small molecule discovery into the new research area of antibody drug discovery. All three ...
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Press Release from Business Wire : Takeda Pharmaceutical Company Limited
The Global Alliance for TB Drug Development (Headquarters: New York, USA, "TB Alliance") and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan; "Takeda") announced that they have entered into an agreement that further explores ...
Progress MN: Takeda Pharmaceutical Co. Limited
Sometimes the right property comes along at the right time. That was the case for the Minnesota division of Takeda, the Japan-based pharmaceutical giant, when it found a 215,000-square-foot building in Brooklyn Park that had previously been occupied by ...
Takeda Pharmaceutical Co Ltd sets bidding deadline for chemical firm stake ...
Takeda Pharmaceutical Co Ltd will accept initial bids for its 70 percent stake in a chemicals company through Aug. 16, with potential suitors including CVC Capital Partners Ltd and Carlyle Group Ltd, sources told Reuters.
Takeda to Partner with Altos Therapeutics to Develop Promising Compound for ...
BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) and Altos Therapeutics LLC today jointly announced the companies have entered into a definitive agreement to further the development of Altos's proprietary compound ATC-1906.
Takeda Appoints New Chief Financial Officer, James Kehoe
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) today announced the appointment of James Kehoe as Takeda's new Chief Financial Officer and Corporate Officer, effective on June 15, 2016.
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of ...
JERUSALEM & OSAKA, Japan--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that the two companies have entered into a definitive ...
Teva, Takeda strike generic drug distribution deal in Japan  Philly.com
Takeda, Teva to Form Partnership in Japan For Generic Drug Sales  Bloomberg
Takeda Pharmaceuticals U.S.A., Inc. Announces Plans to Transform Business ...
Also as part of the targeted focus, Takeda has created a General Medicine Business Unit, led by Senior Vice President Thomas Gibbs, most recently of Vanda Pharmaceuticals, to support operations and marketing of the company's medicines in the areas of ...
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
JERUSALEM & OSAKA, Japan--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Takeda Pharmaceutical Company Limited (TSE:4502) announce the establishment of Teva Takeda Yakuhin Ltd. (“Teva Takeda Yakuhin”).